Celularity Inc Quarterly Debt-to-equity in % from Q1 2020 to Q3 2024

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: Celularity Inc quarterly Debt-to-equity history and growth rate from Q1 2020 to Q3 2024.
Celularity Inc Debt-to-equity for the quarter ending September 30, 2024 was 371 %, a 181% increase year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q3 2024	371	+239	+181%	Sep 30, 2024
Q2 2024	346	+218	+172%	Jun 30, 2024
Q1 2024	213	+69.2	+48.2%	Mar 31, 2024
Q4 2023	163	-18.6	-10.2%	Dec 31, 2023
Q3 2023	132	-109	-45.1%	Sep 30, 2023
Q2 2023	127	-169	-57.1%	Jun 30, 2023
Q1 2023	144	+436		Mar 31, 2023
Q4 2022	182	+253		Dec 31, 2022
Q3 2022	240	+291		Sep 30, 2022
Q2 2022	296	+318		Jun 30, 2022
Q1 2022	-292	-270	-1237%	Mar 31, 2022
Q4 2021	-70.8	-47.6	-205%	Dec 31, 2021
Q3 2021	-50.2	-46.7	-1306%	Sep 30, 2021
Q2 2021	-21.9	-16.7	-319%	Jun 30, 2021
Q1 2021	-21.8	-12.8	-140%	Mar 31, 2021
Q4 2020	-23.2			Dec 31, 2020
Q3 2020	-3.57			Sep 30, 2020
Q2 2020	-5.23			Jun 30, 2020
Q1 2020	-9.08			Mar 31, 2020

* An asterisk sign (*) next to the value indicates that the value is likely invalid.